These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35264143)

  • 1. The congruency of neuropsychological and F18-FDG brain PET/CT diagnostics of Alzheimer's Disease (AD) in routine clinical practice: insights from a mixed neurological patient cohort.
    Hansen S; Keune J; Küfner K; Meister R; Habich J; Koska J; Förster S; Oschmann P; Keune PM
    BMC Neurol; 2022 Mar; 22(1):83. PubMed ID: 35264143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Relevance of [
    Librizzi D; Cabanel N; Zavorotnyy M; Riehl E; Kircher T; Luster M; Hooshyar Yousefi B
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33652938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact and diagnostic accuracy of 2-[
    Motara H; Olusoga T; Russell G; Jamieson S; Ahmed S; Brindle N; Pillai A; Scarsbrook AF; Patel CN; Chowdhury FU
    Clin Radiol; 2017 Jan; 72(1):63-73. PubMed ID: 27637430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage-dependent agreement between cerebrospinal fluid proteins and FDG-PET findings in Alzheimer's disease.
    Yakushev I; Muller MJ; Buchholz HG; Lang U; Rossmann H; Hampel H; Schreckenberger M; Fellgiebel A
    Curr Alzheimer Res; 2012 Feb; 9(2):241-7. PubMed ID: 22044023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain metabolic patterns in patients with suspected non-Alzheimer's pathophysiology (SNAP) and Alzheimer's disease (AD): is [
    Chiaravalloti A; Barbagallo G; Martorana A; Castellano AE; Ursini F; Schillaci O
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1796-1805. PubMed ID: 31201430
    [TBL]